Global  

Nasal Spray Used By Healthcare Workers Kills COVID-19 In Fifteen Seconds

Video Credit: Wochit News - Duration: 00:34s - Published
Nasal Spray Used By Healthcare Workers Kills COVID-19 In Fifteen Seconds

Nasal Spray Used By Healthcare Workers Kills COVID-19 In Fifteen Seconds

A new study reveals a nasal antiseptic solution 'inactivates' COVID-19 just 15 seconds after the coronavirus is exposed to it.

According to UPI, the solution effectively prevents the infection from developing.

When the commercially available povidone-iodine solution is administered, it also helps prevent people from spreading it to others.

The rinse is sold under the brand name Halodine.

It's used by healthcare workers to prevent the spread of infection, and is also available as an oral rinse.


You Might Like


💡 One News Page Knowledge: Other News Mentions

United Press International United Press International International news agency

New Test Identifies Patients At Risk For Severe COVID-19 [Video]

New Test Identifies Patients At Risk For Severe COVID-19

Researchers in Ireland say they have developed a system that can predict who will suffer from severe COVID-19. According to UPI, the team of researchers revealed their study and findings on Wednesday. The scoring system, called the Dublin-Boston score, is designed to enable clinicians to make more informed decisions. Physicians will be able to identify patients who may benefit from steroids and other treatments after being infected.

Credit: Wochit News    Duration: 00:31Published
COVID-19 Patients Produce 'High-Quality' Antibodies [Video]

COVID-19 Patients Produce 'High-Quality' Antibodies

UPI reports people sickened with COVID-19 produce "high-quality" antibodies. The antibodies work against the virus five to seven months after they become infected. The findings suggest those infected with COVID-19 potentially can develop a long-lasting immunity to it. Antibodies are proteins produced by the human immune system to help the body fight off viruses. Many concerns have been expressed about immunity against COVID-19 not lasting.

Credit: Wochit News    Duration: 00:36Published
Rapid Bedside COVID-19 Test Gives Results In Two Hours, Not Twenty [Video]

Rapid Bedside COVID-19 Test Gives Results In Two Hours, Not Twenty

A new, rapid, bedside test for COVID-19 delivers results in less than two hours. UPI reports a new study says such a quick turnaround means appropriate treatment can start earlier for those already hospitalized because of their symptoms. The standard COVID-19 test swabs the patient's nose and uses polymerase chain reaction, or PCR, technology. It typically takes over 20 hours to produce results.

Credit: Wochit News    Duration: 00:37Published
Who's Most Likely To Break Social Distancing Guidelines? [Video]

Who's Most Likely To Break Social Distancing Guidelines?

New research from Harvard and Calgary Universities have shed new light on who is more or less likely to observe COVID-19 social distancing guidelines. UPI reports more North American and European men, and young adults of both sexes, fail to adhere to COVID-19 social distancing guidelines than older adults. The data showed 59% of male respondents said they adhered to local social distancing guidelines, while 69% of female respondents reported doing so.

Credit: Wochit News    Duration: 00:37Published
Survey: COVID-19 Persuades Many Americans To Get Seasonal Flu Jab [Video]

Survey: COVID-19 Persuades Many Americans To Get Seasonal Flu Jab

During the 2019-20 flu season, 52% of people in the US were vaccinated against the seasonal influenza. And results of a new survey by the National Foundation for Infectious Diseases are likely to have public health officials cheering. UPI reports that of the 1,000 people surveyed, 60% of people in the United States plan to be vaccinated against the flu this winter. Nearly half said they were concerned about the potential effects of the novel coronavirus COVID-19 on the seasonal bug.

Credit: Wochit News    Duration: 00:34Published

Tweets about this